Clinical Trials Browser

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Intestinal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07344116 2026-01-15

Hepatobiliary and Pancreatic Tumor Biobank

Not yet recruiting

300 enrolled

Gastrointestinal

Pancreatic Neoplasms, Cholangiocarcinoma

NCT07325214 2026-01-12

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

Phase NA Not yet recruiting

136 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07272109 2025-12-15

PTCA199-16

Phase 3 Not yet recruiting

210 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07260617 2025-12-03

ONCONUTRIBIOTA

Not yet recruiting

150 enrolled

Gastrointestinal

Gastrointestinal Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Malnutrition

NCT07262567 2025-12-03

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

Phase 3 Not yet recruiting

320 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06755359 2025-12-02

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

Phase NA Not yet recruiting

40 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07242911 2025-11-21

Study on Efficacy and Safety of VMAT Technique With Local Dose Escalation for Unresectable Pancreatic Cancer

Not yet recruiting

30 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT06177522 2025-11-18

Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

Phase 2 Not yet recruiting

30 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07219238 2025-10-21

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

Phase 2/3 Not yet recruiting

175 enrolled

GastrointestinalGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07208539 2025-10-06

ZSPAC-14

Phase 2 Not yet recruiting

77 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07206355 2025-10-03

Map HPB

Not yet recruiting

160 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Cyst, Pancreatic Neoplasms, Cholangiocarcinoma

NCT07175389 2025-09-16

JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure

Phase 1/2 Not yet recruiting

10 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT07176052 2025-09-16

Expectation, Pain Outcomes, and Pain Medication Following Oncology Abdominal Surgery: A Cohort Study

Not yet recruiting

200 enrolled

Gastrointestinal

Esophageal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Acute Pain

Clinical Trials

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

ОС26

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors

ChefHat-001

Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer

MIND-PANC

SURGIMEDIA

PRE-PDAC

Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies

PAN-Plastic

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

ResQ108B-PANC

HY-PANC

PRISM-TAMP

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

U-TRANS

WATCH AND ACT

Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain

PAN-CLO-BU

GENTLENESS

IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.

Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer

Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer

Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing

Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer

MRinRT

FAST

AxeCan

SL-28 for Advanced Solid Tumours

Hepatobiliary and Pancreatic Tumor Biobank

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

PTCA199-16

ONCONUTRIBIOTA

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

Study on Efficacy and Safety of VMAT Technique With Local Dose Escalation for Unresectable Pancreatic Cancer

Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

ZSPAC-14

Map HPB

JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure

Expectation, Pain Outcomes, and Pain Medication Following Oncology Abdominal Surgery: A Cohort Study